Paediatric investigation plan (PIP) - Key elements form
Submitted by Anonymous (not verified) on 8 August 2025 - 9:26
Paediatric investigation plan (PIP) - Key elements form
Procedural advice on paediatric applications
Submitted by Anonymous (not verified) on 8 August 2025 - 9:24
Procedural advice on paediatric applications
Paediatric medicines: applications and procedures
Submitted by Anonymous (not verified) on 8 August 2025 - 9:23
Paediatric medicines: applications and procedures
Key elements form: Applicant’s proposal for a paediatric-investigation-plan opinion
Submitted by Anonymous (not verified) on 8 August 2025 - 9:22
Key elements form: Applicant’s proposal for a paediatric-investigation-plan opinion
3Rs Working Party (3RsWP) plenary meeting - Public session on the 2025-2027 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 April 2025, 09:30 (CEST) to 2 April 2025, 10:30 (CEST)
Submitted by Anonymous (not verified) on 8 August 2025 - 8:37
3Rs Working Party (3RsWP) plenary meeting - Public session on the 2025-2027 work plan, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 April 2025, 09:30 (CEST) to 2 April 2025, 10:30 (CEST)
Emergency Task Force (ETF)
Submitted by Anonymous (not verified) on 7 August 2025 - 15:51
Emergency Task Force (ETF)
Composition of the Emergency Task Force (ETF) for preparedness
Submitted by Anonymous (not verified) on 7 August 2025 - 15:28
Composition of the Emergency Task Force (ETF) for preparedness
Superseded - Composition of the Emergency Task Force (ETF) for preparedness
Submitted by Anonymous (not verified) on 7 August 2025 - 15:26
Superseded - Composition of the Emergency Task Force (ETF) for preparedness
Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 9, Status: Authorised
Submitted by Anonymous (not verified) on 7 August 2025 - 15:00
Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Brintellix, vortioxetine, Date of authorisation: 18/12/2013, Revision: 25, Status: Authorised
Submitted by Anonymous (not verified) on 7 August 2025 - 14:44
Human medicines European public assessment report (EPAR): Brintellix, vortioxetine, Date of authorisation: 18/12/2013, Revision: 25, Status: Authorised